Skip to main content

European product

CE marking

MDR certification

Backed by clinical trials

Private label available

Imagen de DAYDROP ADVANCED DROPPER150x 80
Imagen de DAYDROP ADVANCED DROPPER GOTA150x 80
Imagen de DAYDROP ADVANCED DROPPER ESTUCHE150x 80
Imagen de DAYDROP ADVANCED AMPOYAS150x 80
Imagen de DAYDROP ADVANCED AMPOYAS ESTUCHE150x 80
Imagen de DAYDROP ADVANCED GOTA DATOS EN150x 80

DayDrop Advanced

Eye drops for immediate hydration.

Unique combination of γ-PGA and hyaluronic acid. Phosphate-free and preservative-free.

Main ingredients
Gamma-polyglutamic acid (γ-PGA) and sodium hyaluronate
Presentation (format)
Multidose: 10 mL container with OSD (Ophthalmic Squeeze Dispenser) technology.Single-dose: Low-density polyethylene (LDPE) containers: 0.4 mL x 30, 20 or 5 units.
Certification
Medical Device
Shelf life and PAO
2 yearsPAO: 9 months (multidose)
Technology
γ-PGA + Hyaluronic Acid
Presentation
Multidose: 10 mL container with OSD (Ophthalmic Squeeze Dispenser) technology. Single-dose: Low-density polyethylene (LDPE) containers: 0.4 mL x 30, 20 or 5 units.

GAMHA Technology

Dos veces al día

Compatible con lentes

Libre de fosfatos y conservantes

Tecnología exclusiva

Advantages
  • Immediate and long-lasting hydration.
  • Innovative formula (γ-PGA + HA): γ-PGA protects hyaluronic acid from degradation, enhancing its moisturising effect and improving its adhesion to the eye.
Indications

For the relief of ocular dryness and irritation caused by dry eye syndrome, hormonal changes, ageing or environmental factors.

Properties

• Relieves dry eyes and the sensation of ocular dryness.

• Relieves ocular irritation.

• Improves tear-film quality.

• Compatible with contact lenses.

• Immediate, long-lasting hydration.

Directions for use

Instil one or two drops into each eye twice daily, or as often as directed by your specialist.

Technology

γ-PGA + Hyaluronic Acid

The unique combination of high-molecular-weight hyaluronic acid (HA), which forms a lubricating matrix and retains moisture, with gamma-polyglutamic acid (γ-PGA), which inhibits HA degradation and improves mucoadhesion to the ocular surface.

This combination allows the solution to resist enzymatic biodegradation and remain in place for much longer, stabilising the tear film. The result is advanced corneal protection that soothes ocular dryness and relieves pain and tired-eye symptoms.

Productos relacionados